Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy
Joint Authors
Chopra, Amit
Alappan, Narendrakumar
Shim, Chang
Marak, Creticus P.
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-01-29
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Hepatitis C virus infection is the leading cause of chronic liver disease in the United States of America.
Pegylated interferon α and ribavirin combination is the mainstay of treatment.
Severe pulmonary toxicities are rarely reported.
We report here a case of severe form of organizing pneumonia secondary to pegylated interferon α therapy presenting as acute respiratory failure.
Patient has near complete recovery with withdrawal of pegylated interferon α and steroid therapy.
We report this case to raise the awareness of this rare but potentially life-threatening pulmonary complication of pegylated interferon α therapy.
American Psychological Association (APA)
Chopra, Amit& Marak, Creticus P.& Alappan, Narendrakumar& Shim, Chang. 2015. Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy. Case Reports in Pulmonology،Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1059886
Modern Language Association (MLA)
Chopra, Amit…[et al.]. Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy. Case Reports in Pulmonology No. 2015 (2015), pp.1-4.
https://search.emarefa.net/detail/BIM-1059886
American Medical Association (AMA)
Chopra, Amit& Marak, Creticus P.& Alappan, Narendrakumar& Shim, Chang. Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy. Case Reports in Pulmonology. 2015. Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1059886
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1059886